UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.